From 1 April 2023 all referrals for NHS fertility services in BNSSG have been subject to the revised Infertility Assessment & Treatment Policy.
Main changes in the new policy:
*Age range transition period
The age transition period has now ended and so prospective mothers should only be referred where they are younger than 39 years old.
**Living Offspring / Children
For the purposes of this policy the following definitions will apply:
For heterosexual and same sex couples, if either partner has living offspring, the couple is not able to access NHS fertility services including assessment. For single women, if they have living offspring, they are not able to access NHS fertility services including assessment. (as stated in section A.5 of the Infertility Assessment and Treatment Policy).
As well as genetic children, living offspring also includes legally adopted children. Living offspring also includes children who are now adults.
Living offspring does not include foster children or step children (as long as not living offspring of either partner).
If the individual or couple adopts a child or becomes pregnant naturally before or during assessment or treatment, they will no longer be eligible for NHS fertility assessment or treatment.
There is background information in the Infertility section of the Clinical Knowledge Summary website:
Many couples presenting with a delay in conception of 1 year duration may only need simple investigations and reassurance.
Assessment should include (clearly evidenced in the primary patient records):
Prospective Mother:
Male partner (if appropriate):
If normal reassure and advise couple continue to try for up to 2 years unless there is an indication for early referral (see section below).
Please note that if the prospective mother will be 39 within the two year time frame (they can be referred after one year as long as they can still be referred before their 39th birthday).
Clinical Knowledge Summaries also has details on Initial Assessment of Fertility.
In most cases an individual or couple must try to conceive for 2 years before being eligible for NHS referral. However, there are scenarios that may allow an earlier referral outside of this timeframe as detailed in the policy. This includes:
1. A known condition which is likely to affect fertility in the female partner such as:
2. A known condition which is likely to affect fertility in the male partner such as:
3. Age of female partner
4. If the individual has undergone 6 cycles of independently funded unstimulated IUI using sperm from an HFEA approved source.
5. If there is a sexual health condition where the patient is unable to have penetrative sex. Individuals must have completed all relevant therapy provided by Psychosexual or Andrology services.
Clomiphene (Clomifene) is licensed for use in treatment of anovulatory infertility. It is listed as a blue drug on the BNSSG formulary. Most GPs will not prescribe due to the risk of Ovarian Hyperstimulation Syndrome and the lack of availability of ultrasound monitoring in primary care. Referrals for patients specifically requesting clomiphene will still need to fulfil the referral criteria and follow the same pathway as other fertility referrals.
Women who have had recurrent miscarriages are not suitable for referral to fertility clinic. A referral to the Recurrent Miscarriage clinic may be more appropriate if criteria are met.
If a woman has conceived and then had a miscarriage following a period of infertility, a referral for fertility investigation can only be made once they fulfil the criteria within the policy. e.g. If they then fail to conceive for a further 2 years, or if there is another indication for a referral before this time.
Heterosexual and same sex couples being referred for Fertility Assessment / Treatment are referred as a couple and not individually as both partners are involved in this process. Although only one partner needs to be registered at the referring GP Practice, it will be the responsibility of that GP practice to ensure that all the relevant information / tests are available for both parties prior to submitting the referral. This will mean co-ordinating with the other partner’s GP practice. The referral would usually be done by the GP practice of the prospective mother.
Referrals for infertility assessment are subject to the criteria based access (CBA) part of the Infertility Assessment & Treatment Policy and, as such the Infertility Assessment Referral form (available on EMIS) must be completed by the referring GP, demonstrating that the criteria have been met. This form also includes the preliminary investigations required by the trusts and hard copy tests results must be attached to the referral. It is recommended that investigation results should be no longer a year old at time of referral.
A copy of the male partner’s semen analysis should also be attached to the referral if appropriate. Please note that a second semen analysis will be required if the result of the first is abnormal, suboptimal, show a low sperm count or even azoospermia. See the Semen Analysis page for further details and referral process.
If all relevant information is not provided, the referral may be returned by the Referral Service and/or the provider.
Referrals should be directed via e-Referral and patients will be offered a choice of one of the following providers:
St Michaels Hospital - Reproductive medicine clinic
Royal United Hospital (RUH) Reproductive Medicine clinics are held at two locations; CARE Fertility Bath at Peasedown St John, Bath and CARE Fertility Bristol at Aztec West, Bristol. Outpatient bookings can be made through the eReferral system. GP enquiries can be made directly to CARE Fertility Bath on 01761 438590.
Southmead Hospital - Southmead General Fertility Clinic on eReferral. Contact Details for Southmead General Infertility Service: 0117 414 7171 for GP queries. 0117 414 6757 for outpatients booking.
Patients can be seen in these clinics for assessment and investigation and then referred on to a suitable provider for assisted conception is this is necessary (see section below)
Please note - This section applies to referrals from specialists and not to GP referrals:
All referrals for Assisted Conception treatments, coming from General Infertility consultants/gynaecologists are managed by the Individual Funding Request Team who notify couples of eligibility and their options to enable them to choose their provider.
Couples or single women meeting the NHS eligibility criteria for Assisted Conception Treatments have access to a choice of six HFEA Licensed providers of IVF and other fertility treatments. These providers have all been contracted on an approved provider framework having demonstrated they can meet the quality and service standards we have set on behalf of our population, including success and complication rates that are in line with or better than national average.
Eligible couples will be offered choice of the following five providers when their funding is confirmed, with details of each clinic and where to get more information to inform their decision.
The freezing and storage of sperm, oocytes and embryos is subject to the ICB's Fertility Preservation Treatment policy.
Funding approval will be provided to patients who receive NHS treatment where there is an adverse, long-term impact on fertility for which there is no clear alternative, and where the individual meets the rest of the criteria. Patients who are to receive oncology treatments which are likely to compromise their fertility are also eligible for fertility preservation, as well as patients prescribed cyclophosphamide, and those prescribed testosterone on the gender dysphoria pathway.
The referral form is available via the link above and also via EMIS.
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.